121579-86-0 Usage
General Description
Tert-Butyl 4-(chloromethyl)benzoate is a chemical compound with the molecular formula C13H15ClO2. It is an ester derived from benzoic acid and tert-butyl alcohol, with a chloromethyl group attached to the benzene ring. tert-Butyl 4-(chloromethyl)benzoate is commonly used as a reagent in organic synthesis and as a building block for the preparation of various pharmaceuticals and agrochemicals. It is a colorless to pale yellow liquid with a slightly sweet odor, and it is flammable and can cause irritation to the eyes, skin, and respiratory system. Tert-Butyl 4-(chloromethyl)benzoate should be handled and stored with caution and in compliance with all applicable safety regulations.
Check Digit Verification of cas no
The CAS Registry Mumber 121579-86-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,5,7 and 9 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 121579-86:
(8*1)+(7*2)+(6*1)+(5*5)+(4*7)+(3*9)+(2*8)+(1*6)=130
130 % 10 = 0
So 121579-86-0 is a valid CAS Registry Number.
InChI:InChI=1/C12H15ClO2/c1-12(2,3)15-11(14)10-6-4-9(8-13)5-7-10/h4-7H,8H2,1-3H3
121579-86-0Relevant articles and documents
Silver-Catalyzed C(sp3)-H Chlorination
Ozawa, Jun,Kanai, Motomu
supporting information, p. 1430 - 1433 (2017/03/23)
A silver-catalyzed chlorination of benzylic, tertiary, and secondary C(sp3)-H bonds was developed. The reaction proceeded with as low as 0.2 mol % catalyst loading at room temperature under air atmosphere with synthetically useful functional group compatibility. The regioselectivity and reactivity tendencies suggest that the chlorination proceeded through a radical pathway, but an intermediate alkylsilver species cannot be ruled out.
GLUCAGON ANTAGONISTS
-
Page/Page column 73-74, (2010/04/03)
Provided herein are compounds, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or co-crystals and prodrugs thereof which have glucagon receptor antagonist or inverse agonist activity. Further, provided herein are pharm